Amphastar Pharmaceuticals, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Amphastar Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 21.89K shares, a 90.86% decline year-over-year.
- Amphastar Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 156.50K shares, a 75.55% decline year-over-year.
- Amphastar Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 38.76K shares, a 66.92% decline year-over-year.
- Amphastar Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 27.85K shares, a 86.32% decline year-over-year.
- Amphastar Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 946.22K shares, a 45.25% decline from fiscal 2024.
- Amphastar Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 1.73M shares, a 87.69% increase from fiscal 2023.
- Amphastar Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 920.82K shares, a 24.66% decline from fiscal 2022.
- Amphastar Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 1.22M shares, a 6.16% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 21.89K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 245.00K shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 156.50K shares 10-Q · filed 2026-05-07 | 462.57K shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | 38.76K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 946.22K shares 10-K · filed 2026-02-26 |
| 2025-09-30 | 27.85K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 1.02M shares derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-06-30 | 239.46K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | 1.20M shares derived: sum of 4 quarters · filed 2025-08-07 |
| 2025-03-31 | 640.15K shares 10-Q · filed 2025-05-08 | 1.21M shares derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-12-31 | 117.18K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | 1.73M shares 10-K · filed 2025-03-03 |
| 2024-09-30 | 203.58K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 1.75M shares derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-06-30 | 246.80K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | 1.69M shares derived: sum of 4 quarters · filed 2024-08-09 |
| 2024-03-31 | 1.16M shares 10-Q · filed 2024-05-10 | 1.98M shares derived: sum of 4 quarters · filed 2024-05-10 |
| 2023-12-31 | 133.93K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | 920.82K shares 10-K · filed 2024-02-29 |
| 2023-09-30 | 144.87K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | 852.37K shares derived: sum of 4 quarters · filed 2023-11-08 |
| 2023-06-30 | 540.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | 777.01K shares derived: sum of 4 quarters · filed 2023-08-09 |
| 2023-03-31 | 102.02K shares 10-Q · filed 2023-05-09 | 528.38K shares derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-12-31 | 65.48K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | 1.22M shares 10-K · filed 2023-03-01 |
| 2022-09-30 | 69.51K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | 1.56M shares derived: sum of 4 quarters · filed 2022-11-08 |
| 2022-06-30 | 291.36K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | 1.79M shares derived: sum of 4 quarters · filed 2022-08-09 |
| 2022-03-31 | 795.79K shares 10-Q · filed 2022-05-10 | 1.92M shares derived: sum of 4 quarters · filed 2022-05-10 |
| 2021-12-31 | 402.91K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | 1.30M shares 10-K · filed 2022-03-11 |
| 2021-09-30 | 304.82K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | 967.15K shares derived: sum of 4 quarters · filed 2021-11-09 |
| 2021-06-30 | 421.18K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | 882.40K shares derived: sum of 4 quarters · filed 2021-08-09 |
| 2021-03-31 | 173.44K shares 10-Q · filed 2021-05-07 | 1.83M shares derived: sum of 4 quarters · filed 2021-05-07 |
| 2020-12-31 | 67.71K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | 1.76M shares 10-K · filed 2021-03-15 |
| 2020-09-30 | 220.07K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | 1.73M shares derived: sum of 4 quarters · filed 2020-11-06 |
| 2020-06-30 | 1.37M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | 1.70M shares derived: sum of 4 quarters · filed 2020-08-07 |
| 2020-03-31 | 104.45K shares 10-Q · filed 2020-05-11 | 398.61K shares derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-12-31 | 34.79K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | 1.30M shares 10-K · filed 2020-03-16 |
| 2019-09-30 | 188.33K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | 1.80M shares derived: sum of 4 quarters · filed 2019-11-08 |
| 2019-06-30 | 71.04K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | 2.23M shares derived: sum of 4 quarters · filed 2019-08-09 |
| 2019-03-31 | 1.00M shares 10-Q · filed 2019-05-10 | 2.21M shares derived: sum of 4 quarters · filed 2019-05-10 |
| 2018-12-31 | 533.86K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | 1.36M shares 10-K · filed 2019-03-15 |
| 2018-09-30 | 623.88K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | 2.65M shares derived: sum of 4 quarters · filed 2018-11-09 |
| 2018-06-30 | 52.61K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | 2.41M shares derived: sum of 4 quarters · filed 2018-08-09 |
| 2018-03-31 | 147.51K shares 10-Q · filed 2018-05-10 | 3.10M shares derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-12-31 | 1.82M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | 2.96M shares 10-K · filed 2018-03-14 |
| 2017-09-30 | 381.84K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | 1.34M shares derived: sum of 4 quarters · filed 2017-11-09 |
| 2017-06-30 | 744.36K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | 1.94M shares derived: sum of 4 quarters · filed 2017-08-09 |
| 2017-03-31 | 8.06K shares 10-Q · filed 2017-05-10 | 1.46M shares derived: sum of 4 quarters · filed 2017-05-10 |
| 2016-12-31 | 203.52K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | 1.47M shares 10-K · filed 2017-03-15 |
| 2016-09-30 | 981.72K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | 1.45M shares derived: sum of 4 quarters · filed 2016-11-09 |
| 2016-06-30 | 271.10K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | 540.63K shares derived: sum of 4 quarters · filed 2016-08-09 |
| 2016-03-31 | 9.20K shares 10-Q · filed 2016-05-10 | 1.20M shares derived: sum of 4 quarters · filed 2016-05-10 |
| 2015-12-31 | 191.82K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | 1.26M shares 10-K · filed 2016-03-15 |
| 2015-09-30 | 68.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | 1.07M shares derived: sum of 4 quarters · filed 2016-03-15 |
| 2015-06-30 | 927.52K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | 1.04M shares derived: sum of 4 quarters · filed 2016-03-15 |
| 2015-03-31 | 74.82K shares 10-Q · filed 2015-05-14 | |
| 2014-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | 65.00K shares 10-K · filed 2016-03-15 |
| 2014-09-30 | 35.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | |
| 2013-12-31 | 4.20K shares 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |